Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
This report contains market size and forecasts of Paclitaxel Injection in global, including the following market information:
Global Paclitaxel Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Paclitaxel Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Paclitaxel Injection companies in 2021 (%)
The global Paclitaxel Injection market was valued at 3482 million in 2021 and is projected to reach US$ 7058.9 million by 2028, at a CAGR of 10.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5ml,30mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paclitaxel Injection include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare and Beijing Union, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paclitaxel Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paclitaxel Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paclitaxel Injection Market Segment Percentages, by Type, 2021 (%)
5ml,30mg
10ml,60mg
16.7ml,100mg
25ml,150mg
50ml,300mg
Global Paclitaxel Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paclitaxel Injection Market Segment Percentages, by Application, 2021 (%)
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Other
Global Paclitaxel Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Paclitaxel Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paclitaxel Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Paclitaxel Injection revenues share in global market, 2021 (%)
Key companies Paclitaxel Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Paclitaxel Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch